Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.
Ul Haq S, Schmid S, Aparnathi MK, Hueniken K, Zhan LJ, Sacdalan D, Li JJN, Meti N, Patel D, Cheng D, Philip V, Tsao MS, Cabanero M, de Carvalho D, Liu G, Bratman SV, Lok BH. Ul Haq S, et al. Among authors: cheng d. iScience. 2022 Nov 4;25(12):105487. doi: 10.1016/j.isci.2022.105487. eCollection 2022 Dec 22. iScience. 2022. PMID: 36425756 Free PMC article.
Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.
Wong KM, Qiu X, Cheng D, Azad AK, Habbous S, Palepu P, Mirshams M, Patel D, Chen Z, Roberts H, Knox J, Marquez S, Wong R, Darling G, Waldron J, Goldstein D, Leighl N, Shepherd FA, Tsao M, Der S, Reisman D, Liu G. Wong KM, et al. Among authors: cheng d. Cancer Med. 2014 Apr;3(2):426-33. doi: 10.1002/cam4.201. Epub 2014 Feb 12. Cancer Med. 2014. PMID: 24519853 Free PMC article.
A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK, Qiu X, Boyd K, Kuang Q, Emami M, Perera N, Palepu P, Patel D, Chen Z, Cheng D, Feld R, Leighl NB, Shepherd FA, Tsao MS, Xu W, Liu G, Cuffe S. Azad AK, et al. Among authors: cheng d. Lung Cancer. 2014 Jun;84(3):289-94. doi: 10.1016/j.lungcan.2014.03.008. Epub 2014 Mar 13. Lung Cancer. 2014. PMID: 24679952
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients.
Cuffe S, Azad AK, Qiu X, Qiu X, Brhane Y, Kuang Q, Marsh S, Savas S, Chen Z, Cheng D, Leighl NB, Goss G, Laurie SA, Seymour L, Bradbury PA, Shepherd FA, Tsao MS, Chen BE, Xu W, Liu G. Cuffe S, et al. Among authors: cheng d. Cancer Epidemiol. 2016 Apr;41:50-6. doi: 10.1016/j.canep.2015.12.012. Epub 2016 Jan 24. Cancer Epidemiol. 2016. PMID: 26816351
BRM polymorphisms, pancreatic cancer risk and survival.
Segedi M, Anderson LN, Espin-Garcia O, Borgida A, Bianco T, Cheng D, Chen Z, Patel D, Brown MC, Xu W, Reisman D, Gallinger S, Cotterchio M, Hung R, Liu G, Cleary SP. Segedi M, et al. Among authors: cheng d. Int J Cancer. 2016 Dec 1;139(11):2474-81. doi: 10.1002/ijc.30369. Epub 2016 Aug 18. Int J Cancer. 2016. PMID: 27487558 Free article.
BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.
Liu G, Cuffe S, Liang S, Azad AK, Cheng L, Brhane Y, Qiu X, Cescon DW, Bruce J, Chen Z, Cheng D, Patel D, Tse BC, Laurie SA, Goss G, Leighl NB, Hung R, Bradbury PA, Seymour L, Shepherd FA, Tsao MS, Chen BE, Xu W, Reisman DN. Liu G, et al. Among authors: cheng l, cheng d. Clin Cancer Res. 2017 May 15;23(10):2460-2470. doi: 10.1158/1078-0432.CCR-16-1640. Epub 2016 Nov 8. Clin Cancer Res. 2017. PMID: 27827316 Free PMC article. Clinical Trial.
4,522 results